- Related Products
MedEx answers any queries you might have regarding Sutent-12.5 purchase, shipping and payment terms.
Feel free to contact support through inquiry form, MedeEx is fully dedicated towards your needs 24/7.
Indication for use and dosage of Sutent 12,5 mg:
Gastrointestinal stromal tumors in patients, intolerant to imatinib mesylate (or if the treatment was unsuccessful).
Untreated locally advanced and/or metastatic clear cell renal cell carcinoma.
Locally advanced and/or metastatic clear cell renal cell carcinoma, if the previous cytokine therapy was ineffective.
Therapy must be conducted by the doctor, experienced in the treatment of metastatic clear cell renal cell carcinoma or gastrointestinal stromal tumors.
Recommended daily dose of Sutent 12,5 mg is 25 mg; you should take the drug for four consecutive weeks, and then take a 2-week break (treatment scheme “4/2”). The full treatment cycle lasts 6 weeks. Sutent can be taken irrespective of the mealtime. If you skipped the pill, you shouldn’t double the dose. Next day, just take a usual dose.
Sutent 12,5 mg is a drug, intended for the treatment of cancer. It acts by impeding the activity of a specific group of proteins, responsible for the growth and replication of tumor cells.
This drug can be prescribed only by the health professional, experienced in the use of antitumor agents.
Gastrointestinal stromal tumour
Sutent is intended for the treatment of metastatic and/or inoperable malignant gastrointestinal stromal tumour in adult people (if the treatment with Imatinib wasn’t successful or if the patient’s body is resistant to this substance). G Gastrointestinal stromal tumour is a cancer of GI tract, arising from uncontrolled cell growth of the connective tissues of stomach and intestines. SUTENT prevents the growth of cancer cells.
Metastatic renal cell carcinoma
Sutent is intended for the use of advanced and/or metastatic renal cell carcinoma in adult people. Metastatic renal cell carcinoma is a type of renal cancer that suggests malignant transformations in the renal tubule cells.
Pancreatic neuroendocrine tumours (pNET)
Sutent 12,5 mg is intended for the treatment of inoperable and/or metastatic pancreatic neuroendocrine tumors with disease development in adult people. Pancreatic neuroendocrine tumour is an uncommon cancer arising in the pancreas.
Experience with Sutent as first-line drug is limited.
How to achieve the best effect from your therapy?
Don’t skip any medical appointments so that your doctor can monitor your progress. You’ll have to do regular blood tests and come for regular check-ups during the therapy.
Sunitinib can change the color of your urine. However, this is harmless and nothing to worry about.
Sunitinib can reduce your blood sugar and cause hypoglycemia. Symptoms of this disease include fatigue, shivering, increased heart rate, perspiration, cold and sticky skin. You should eat or drink something sweet to increase your blood sugar. However, you must also consult your physician. If you suffer from diabetes, you should warn your doctor so that he/she can correct your treatment and do regular blood tests.
Before using any other drugs, contact your doctor to make sure that you can take them together with Sutent 12,5 mg.
Perfect oral hygiene is especially important during the treatment with Sunitinib. Brush your teeth twice a day and don’t forget to have routine dental examinations. Inform your dentists about using Sunitinib, because some dental procedures may not be suitable for you.
Keep in mind that you shouldn’t get pregnant during the treatment with Sunitinib. Use the safe contraceptives throughout the therapy.